Availability of documents and information for the annual shareholders' meeting of June 12, 2024
Regulatory News: GeNeuro , a biopharmaceutical company focused on halting the progression of neurodegenerative and autoimmune diseases such as multiple sclerosis , amyotrophic lateral sclerosis ...